CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3,800 enrolled
Drug / intervention
No interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03850457
NCT03850457N/ACompleted

The Incidence, Risk Factors, Diagnosis, Treatments and Burden of Bronchopulmonary Dysplasia (BPD) Among Very Preterm Infants in China: A Nationwide Prospective Cohort Study.

Children's Hospital of Fudan University·observational·Posted Feb 21, 2019·Updated Feb 25, 2025

In Brief

An observational study evaluating No intervention for Bronchopulmonary Dysplasia. Completed, enrolled 3,800 participants across 1 site.

Detailed Summary

This study will establish a nationwide cohort of very preterm infants in China, to investigate the epidemiological characteristics and short-term outcomes of BPD in different NICUs around the country.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesChina

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedFeb 21, 2019
Enrollment StartJan 1, 2020
Primary CompletionNov 30, 2023
Study CompletionMar 31, 2024
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 7.4 years ago

Interventions

No interventionother

The treatments will be determined by their neonatologists and no additional investigational drugs will be applied to the infants included in this study.